Advertisement
Screener

Alexza Pharmaceuticals Inc. Operating Income

Alexza Pharmaceuticals Inc. Operating Income

Alexza Pharmaceuticals Inc. reported Operating Income of -$5.05 million for the 3-month period ending 2016-03-31, per its 10-Q filed 2016-05-13.

Discontinued › Income Statement

us-gaap:OperatingIncomeLoss · last filed 2016-05-13

  • Alexza Pharmaceuticals Inc. operating income (loss) for the quarter ending 2016-03-31 was -$5.05M.
  • Alexza Pharmaceuticals Inc. operating income (loss) for the quarter ending 2015-12-31 was -$9.98M.
  • Alexza Pharmaceuticals Inc. operating income (loss) for the quarter ending 2015-09-30 was -$7.60M.
  • Alexza Pharmaceuticals Inc. operating income (loss) for the quarter ending 2015-06-30 was -$9.44M.
  • Alexza Pharmaceuticals Inc. operating income (loss) for fiscal 2015 was -$40.02M.
  • Alexza Pharmaceuticals Inc. operating income (loss) for fiscal 2014 was -$37.46M, a 2216.16% decline from fiscal 2013.
  • Alexza Pharmaceuticals Inc. operating income (loss) for fiscal 2013 was $1.77M.
  • Alexza Pharmaceuticals Inc. operating income (loss) for fiscal 2012 was -$28.87M.
Period endOperating Income (Loss) 3 monthOperating Income (Loss) 6 monthOperating Income (Loss) 9 monthOperating Income (Loss) 12 monthOperating Income (Loss) 126 monthOperating Income (Loss) 129 monthOperating Income (Loss) 132 monthOperating Income (Loss) 135 monthOperating Income (Loss) 138 monthOperating Income (Loss) 141 month
2016-03-31-$5.05M
10-Q · filed 2016-05-13
-$15.04M
derived: sum of 2 quarters · filed 2016-05-13
-$22.64M
derived: sum of 3 quarters · filed 2016-05-13
-$32.08M
derived: sum of 4 quarters · filed 2016-05-13
2015-12-31-$9.98M
10-K · filed 2016-03-28
-$17.58M
derived: sum of 2 quarters · filed 2016-03-28
-$27.02M
derived: sum of 3 quarters · filed 2016-03-28
-$40.02M
10-K · filed 2016-03-28
2015-09-30-$7.60M
10-K · filed 2016-03-28
-$17.04M
derived: sum of 2 quarters · filed 2016-03-28
-$30.04M
10-Q · filed 2015-11-05
-$37.30M
derived: sum of 4 quarters · filed 2016-05-13
2015-06-30-$9.44M
10-K · filed 2016-03-28
-$22.44M
10-Q · filed 2015-08-06
-$29.71M
derived: sum of 3 quarters · filed 2016-05-13
-$39.75M
derived: sum of 4 quarters · filed 2016-05-13
2015-03-31-$13.00M
10-Q · filed 2016-05-13
-$20.27M
derived: sum of 2 quarters · filed 2016-05-13
-$30.31M
derived: sum of 3 quarters · filed 2016-05-13
-$41.66M
derived: sum of 4 quarters · filed 2016-05-13
2014-12-31-$7.26M
10-K · filed 2016-03-28
-$17.30M
derived: sum of 2 quarters · filed 2016-03-28
-$28.65M
derived: sum of 3 quarters · filed 2016-03-28
-$37.46M
10-K · filed 2016-03-28
2014-09-30-$10.04M
10-K · filed 2016-03-28
-$21.39M
derived: sum of 2 quarters · filed 2016-03-28
-$30.19M
10-Q · filed 2015-11-05
-$39.55M
derived: sum of 4 quarters · filed 2016-03-28
2014-06-30-$11.35M
10-K · filed 2016-03-28
-$20.15M
10-Q · filed 2015-08-06
-$29.51M
derived: sum of 3 quarters · filed 2016-03-28
-$39.85M
derived: sum of 4 quarters · filed 2016-03-28
2014-03-31-$8.80M
10-K · filed 2016-03-28
-$18.16M
derived: sum of 2 quarters · filed 2016-03-28
-$28.50M
derived: sum of 3 quarters · filed 2016-03-28
$2.57M
derived: sum of 4 quarters · filed 2016-03-28
2013-12-31-$9.36M
10-K · filed 2015-03-13
-$19.70M
derived: sum of 2 quarters · filed 2015-03-13
$11.37M
derived: sum of 3 quarters · filed 2015-03-13
$1.77M
10-K · filed 2016-03-28
2013-09-30-$10.34M
10-K · filed 2015-03-13
$20.73M
derived: sum of 2 quarters · filed 2015-03-13
$11.13M
10-Q · filed 2014-11-05
$227.00K
derived: sum of 4 quarters · filed 2015-03-13
2013-06-30$31.07M
10-K · filed 2015-03-13
$21.47M
10-Q · filed 2014-08-07
$10.57M
derived: sum of 3 quarters · filed 2015-03-13
$4.17M
derived: sum of 4 quarters · filed 2015-03-13
2013-03-31-$9.60M
10-K · filed 2015-03-13
-$20.50M
derived: sum of 2 quarters · filed 2015-03-13
-$26.90M
derived: sum of 3 quarters · filed 2015-03-13
-$34.08M
derived: sum of 4 quarters · filed 2015-03-13
2012-12-31-$10.90M
10-K · filed 2014-03-25
-$17.29M
derived: sum of 2 quarters · filed 2014-03-25
-$24.48M
derived: sum of 3 quarters · filed 2014-03-25
-$28.87M
10-K · filed 2015-03-13
2012-09-30-$6.39M
10-K · filed 2014-03-25
-$13.58M
derived: sum of 2 quarters · filed 2014-03-25
-$17.97M
10-Q · filed 2013-11-06
-$26.48M
derived: sum of 4 quarters · filed 2014-03-25
-$368.57M
10-Q · filed 2012-11-06
2012-06-30-$7.19M
10-K · filed 2014-03-25
-$11.58M
10-Q · filed 2013-08-14
-$20.08M
derived: sum of 3 quarters · filed 2014-03-25
-$29.98M
derived: sum of 4 quarters · filed 2014-03-25
-$362.18M
10-Q · filed 2012-08-08
2012-03-31-$4.39M
10-K · filed 2014-03-25
-$12.90M
derived: sum of 2 quarters · filed 2014-03-25
-$22.80M
derived: sum of 3 quarters · filed 2014-03-25
-$30.94M
derived: sum of 4 quarters · filed 2014-03-25
-$354.99M
10-Q · filed 2012-05-10
2011-12-31-$8.50M
10-K · filed 2013-03-26
-$18.40M
derived: sum of 2 quarters · filed 2013-03-26
-$26.55M
derived: sum of 3 quarters · filed 2013-03-26
-$34.37M
10-K · filed 2014-03-25
-$350.60M
10-K · filed 2012-03-12
2011-09-30-$9.90M
10-K · filed 2013-03-26
-$18.04M
derived: sum of 2 quarters · filed 2013-03-26
-$25.86M
10-Q · filed 2012-11-06
$2.72M
derived: sum of 4 quarters · filed 2013-03-26
-$342.10M
10-Q · filed 2011-11-07
2011-06-30-$8.14M
10-K · filed 2013-03-26
-$15.96M
10-Q · filed 2012-08-08
$12.62M
derived: sum of 3 quarters · filed 2013-03-26
$4.10M
derived: sum of 4 quarters · filed 2013-03-26
-$332.19M
10-Q · filed 2011-08-08
2011-03-31-$7.82M
10-K · filed 2013-03-26
$20.76M
derived: sum of 2 quarters · filed 2013-03-26
$12.24M
derived: sum of 3 quarters · filed 2013-03-26
$141.00K
derived: sum of 4 quarters · filed 2013-03-26
2010-12-31$28.59M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-26
$20.07M
derived: sum of 2 quarters · filed 2013-03-26
$7.96M
derived: sum of 3 quarters · filed 2013-03-26
-$4.65M
10-K · filed 2013-03-26
2010-09-30-$8.52M
10-Q · filed 2011-11-07
-$20.62M
derived: sum of 2 quarters · filed 2011-11-07
-$33.24M
10-Q · filed 2011-11-07
2010-06-30-$12.10M
10-Q · filed 2011-08-08
-$24.72M
10-Q · filed 2011-08-08
2009-12-31-$47.71M
10-K · filed 2012-03-12